Drug Information

Drug General Information
Drug ID
D06GQO
Former ID
DNC004502
Drug Name
N-Butyl-N'-(4-methyl-benzoyl)-guanidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526204]
Formula
C13H19N3O
Canonical SMILES
CCCCN=C(N)NC(=O)C1=CC=C(C=C1)C
InChI
1S/C13H19N3O/c1-3-4-9-15-13(14)16-12(17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H3,14,15,16,17)
InChIKey
ALSYKIYWLYFZIK-UHFFFAOYSA-N
PubChem Compound ID
10955473
Target and Pathway
Target(s) Sodium channel protein type 5 subunit alpha Target Info Inhibitor [526204]
KEGG Pathway Adrenergic signaling in cardiomyocytes
PathWhiz Pathway Muscle/Heart Contraction
Reactome Interaction between L1 and Ankyrins
WikiPathways SIDS Susceptibility Pathways
Cardiac Progenitor Differentiation
References
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.
Ref 526204Bioorg Med Chem Lett. 2001 Dec 17;11(24):3151-5.Solution-phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers.